Ocumension Therapeutics

Insider profile

Performance

Overall performance
1.7

Performance over holding periods
1.7
30 days 90 days 120 days
Average return -36% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ocumension Therapeutics's trades of EyePoint Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
165.37
Quantity 3,787 +27.6%
Value US$23,741
Transaction date
Proposed sale
Price
387.61
Quantity 23,680
Value US$1,904,968
Transaction date
Sale
Price
153.15
Quantity 3,855 +46.5%
Value US$1,212,099
Transaction date
Sale
Price
19.91
Quantity 733,758 -24.4%
Value US$14,609,122
Transaction date
Proposed sale
Price
18.34
Quantity 1,000,000
Value US$18,340,000
Transaction date
Proposed sale
Price
5.93
Quantity 3,010,722
Value US$17,853,581
Transaction date
Proposed sale
Price
5.93
Quantity 1
Value US$6
Transaction date
Proposed sale
Price
5.93
Quantity 1
Value US$6
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-01-16 2024-01-11 S Sale
3,787 +27.6%
165.37
US$23,741
3,787 +27.6% 165.37 US$23,741
2024-01-11 2024-01-11 PrS Proposed sale
23,680
387.61
US$1,904,968
23,680 387.61 US$1,904,968
2023-12-07 2023-12-06 S Sale
3,855 +46.5%
153.15
US$1,212,099
3,855 +46.5% 153.15 US$1,212,099
2023-12-07 2023-12-05 S Sale
733,758 -24.4%
19.91
US$14,609,122
733,758 -24.4% 19.91 US$14,609,122
2023-12-05 2023-12-05 PrS Proposed sale
1,000,000
18.34
US$18,340,000
1,000,000 18.34 US$18,340,000
2023-05-26 2023-05-26 PrS Proposed sale
3,010,722
5.93
US$17,853,581
3,010,722 5.93 US$17,853,581
2023-05-26 2023-05-26 PrS Proposed sale
1
5.93
US$6
1 5.93 US$6
2023-05-26 2023-05-26 PrS Proposed sale
1
5.93
US$6
1 5.93 US$6